Clinical Trial Data Transparency on Trial – EMA Under Pressure From Pharma Lawsuit

Thursday 1 December 2016 | Clinical Trial Data | |  Updated 22 December 2016

By Ancel.la Santos, Policy Advisor, Health Action International

For too long, pharmaceutical companies have endangered patient safety by providing biased information about a medicine’s effect on their users.

Conference on Clinical Drug Trials is Coming Up—and You’re Invited

Clinical trials are key to determining the safety and efficacy of medicines. But to do so, trials must be robust and ethical—and their full results must be reported publicly. Unfortunately, many trials are not meeting this criteria. More and more are being off-shored to developing countries where they can be conducted more cheaply and with questionable ethical standards.

HAI urges MEPs to support key amendments to TTIP resolution

by TESSEL MELLEMA and ALIÉNOR DEVALIÈRE, EU Policy Advisors

(UPDATE at 5:15 p.m. on 9 June: The European Parliament vote on TTIP has been postponed to a later date.)

It’s going to be a big day in Strasbourg tomorrow (10 June) as Members of the European Parliament vote on the Transatlantic Trade and Investment Partnership (TTIP) resolution.

START TYPING AND PRESS ENTER TO SEARCH